Saint Vincent and the Grenadines

8 Vaccines Approved for Use in Saint Vincent and the Grenadines

Protein Subunit

Center for Genetic Engineering and Biotechnology (CIGB)

Abdala

Approved in 6 countries
5 trials in 1 country
Approval Source: plenglish.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: health.gov.vc
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: tass.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
6 trials in 1 country
Approval Source: loopnewscaribbean.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: health.gov.vc